Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

CompletedOBSERVATIONAL
Enrollment

126

Participants

Timeline

Start Date

July 22, 2021

Primary Completion Date

November 29, 2023

Study Completion Date

November 29, 2023

Conditions
Vanishing TwinTrisomy 21Trisomy 13Trisomy 18
Trial Locations (21)

10022

NYU Langone, New York

10029

Icahn School of Medicine at Mount Sinai Hospital, New York

10032

Columbia University, New York

10065

Weill Cornell Medicine, New York

10461

Montefiore Medical Center, The Bronx

11501

NYU Long Island, Mineola

18103

Lehigh Valley Health Network, Allentown

19104

University of Pennsylvania, Philadelphia

19718

Christiana Care, Newark

32405

Emerald Coast ObGyn, Panama City

48073

Beaumont, Royal Oak

48109

University of Michigan, Ann Arbor

55905

Mayo Clinic, Rochester

66160

University of Kansas, Kansas City

75039

Cedar Health Research, Irving

80045

University of Colorado, Aurora

90048

Center for Fetal Medicine & Women's Ultrasound, Los Angeles

94304

Stanford, Palo Alto

06511

Yale, New Haven

07753

Hackensack, Neptune City

08901

St. Peter's University Hospital, New Brunswick

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Natera, Inc.

INDUSTRY

NCT05004337 - Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies | Biotech Hunter | Biotech Hunter